Advertisement
RDNT vs TMDX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDNT is a Hold and TMDX is a Hold.
Momentum Indicator for RDNT turns positive, indicating new upward trend
RDNT saw its Momentum Indicator move above the 0 level on October 22, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 70 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for RDNT just turned positive on October 22, 2026. Looking at past instances where RDNT's MACD turned positive, the stock continued to rise in 42 of 55 cases over the following month. The odds of a continued upward trend are 76%.
Following a +1.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDNT advanced for three days, in 233 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 59 cases where RDNT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
RDNT moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RDNT crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for RDNT entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.045) is normal, around the industry mean (66.046). RDNT's P/E Ratio (-270.231) is considerably lower than the industry average of (2.422). Projected Growth (PEG Ratio) (0.260) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.567) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating fairly steady price growth. RDNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
TMDX in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 16, 2026
TMDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 23 of 26 cases where TMDX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TMDX's RSI Indicator exited the oversold zone, 28 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 53 cases where TMDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
Following a +5.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMDX advanced for three days, in 258 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TMDX as a result. In 76 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
TMDX moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TMDX crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for TMDX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. TMDX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.823) is normal, around the industry mean (2.874). P/E Ratio (16.193) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.709) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (5.033) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TMDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
RDNT | TMDX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 4 | 22 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 1 Undervalued | 72 Overvalued | |
PROFIT vs RISK RATING 1..100 | 45 | 76 | |
SMR RATING 1..100 | 91 | 28 | |
PRICE GROWTH RATING 1..100 | 49 | 64 | |
P/E GROWTH RATING 1..100 | 60 | 95 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RDNT's Valuation (1) in the Medical Or Nursing Services industry is significantly better than the same rating for TMDX (72) in the Medical Specialties industry. This means that RDNT’s stock grew significantly faster than TMDX’s over the last 12 months.
RDNT's Profit vs Risk Rating (45) in the Medical Or Nursing Services industry is in the same range as TMDX (76) in the Medical Specialties industry. This means that RDNT’s stock grew similarly to TMDX’s over the last 12 months.
TMDX's SMR Rating (28) in the Medical Specialties industry is somewhat better than the same rating for RDNT (91) in the Medical Or Nursing Services industry. This means that TMDX’s stock grew somewhat faster than RDNT’s over the last 12 months.
RDNT's Price Growth Rating (49) in the Medical Or Nursing Services industry is in the same range as TMDX (64) in the Medical Specialties industry. This means that RDNT’s stock grew similarly to TMDX’s over the last 12 months.
RDNT's P/E Growth Rating (60) in the Medical Or Nursing Services industry is somewhat better than the same rating for TMDX (95) in the Medical Specialties industry. This means that RDNT’s stock grew somewhat faster than TMDX’s over the last 12 months.
| RDNT | TMDX | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 88% |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 83% |
| Momentum ODDS (%) | 1 day ago 81% | 1 day ago 88% |
| MACD ODDS (%) | 1 day ago 76% | N/A |
| TrendWeek ODDS (%) | 1 day ago 73% | 1 day ago 80% |
| TrendMonth ODDS (%) | 1 day ago 75% | 1 day ago 84% |
| Advances ODDS (%) | 3 days ago 74% | 3 days ago 84% |
| Declines ODDS (%) | 15 days ago 74% | 1 day ago 80% |
| BollingerBands ODDS (%) | N/A | 1 day ago 88% |
| Aroon ODDS (%) | 1 day ago 84% | 1 day ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RDNT’s FA Score shows that 1 FA rating(s) are green while TMDX’s FA Score has 1 green FA rating(s).
- RDNT’s FA Score: 1 green, 4 red.
- TMDX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RDNT’s TA Score shows that 1 TA indicator(s) are bullish while TMDX’s TA Score has 4 bullish TA indicator(s).
- RDNT’s TA Score: 1 bullish, 7 bearish.
- TMDX’s TA Score: 4 bullish, 5 bearish.
Price Growth
RDNT (@Medical Specialties) experienced а -1.08% price change this week, while TMDX (@Medical/Nursing Services) price change was -4.13% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.15%. For the same industry, the average monthly price growth was -6.50%, and the average quarterly price growth was +42.74%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
RDNT is expected to report earnings on Nov 09, 2026.
TMDX is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Medical Specialties (-3.15% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
RDNT and
Correlation & Price change
A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with ITGR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then ITGR could also see price increases.
| Ticker / NAME | Correlation To RDNT | 1D Price Change % | ||
|---|---|---|---|---|
| RDNT | 100% | +2.70% | ||
| ITGR - RDNT | 49% Loosely correlated | -0.11% | ||
| GKOS - RDNT | 48% Loosely correlated | -0.09% | ||
| NNOX - RDNT | 46% Loosely correlated | -0.36% | ||
| ICUI - RDNT | 43% Loosely correlated | +4.66% | ||
| CERS - RDNT | 42% Loosely correlated | -3.35% | ||
More | ||||
TMDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with ATEC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then ATEC could also see price increases.
| Ticker / NAME | Correlation To TMDX | 1D Price Change % | ||
|---|---|---|---|---|
| TMDX | 100% | -0.47% | ||
| ATEC - TMDX | 46% Loosely correlated | +4.60% | ||
| PODD - TMDX | 37% Loosely correlated | +4.38% | ||
| RDNT - TMDX | 35% Loosely correlated | +2.70% | ||
| SMTI - TMDX | 34% Loosely correlated | +0.34% | ||
| ALGN - TMDX | 33% Loosely correlated | +2.74% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GMOD | 27.74 | 0.02 | +0.09% |
| GMO Dynamic Allocation ETF (GMOD) | |||
| IEUS | 69.73 | -0.82 | -1.16% |
| iShares MSCI Europe Small-Cap ETF (IEUS) | |||
| HCMT | 40.15 | -1.73 | -4.14% |
| Direxion HCM Tactical Enhanced US ETF (HCMT) | |||
| BETE | 38.12 | -1.65 | -4.14% |
| ProShares Bitcoin & Ether Equal Weight ETF (BETE) | |||
| FLTW | 99.88 | -4.85 | -4.63% |
| Franklin FTSE Taiwan ETF (FLTW) | |||